Clinical Trial Update: A Phase 0, Open Label, Multi-Center, Exploratory and Safety Study of [F-18]T808 [EARLY_Phase 1]

View source ↗

Summary

A Phase 0, open-label, multi-center exploratory safety study of [F-18]T808 for Alzheimer's disease has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• [F-18]T808

Snippet

Sponsor: Avid Radiopharmaceuticals | Conditions: Alzheimers Disease | EARLY_Phase 1 | Status: TERMINATED